Synopsis of recent research by authors named "WeiLi Yin"
- Weili Yin's recent research has focused on hepatocellular carcinoma (HCC), particularly strategies for managing high recurrence rates and evaluating treatment outcomes in patients undergoing transarterial chemoembolization (TACE) and immunotherapy after initial treatments.
- Yin has also explored the impact of digital transformation on green innovation, emphasizing the need for organizational support alongside technological advancements to enhance ecological sustainability in business practices.
- Another significant area of study involved the durability of immune responses to COVID-19 vaccinations in patients with chronic liver disease, providing insights into the effectiveness of vaccination protocols in vulnerable populations.
